Skip to main content

Piasky

NDC 50242-115 · Genentech, Inc.

Generic nameCrovalimab
Dosage formINJECTION, SOLUTION
RouteSUBCUTANEOUS
Active ingredient(s)CROVALIMAB
Strength340 mg/2mL
Pharmacologic classComplement C5 Inhibitor [EPC], Complement C5 Inhibitors [MoA]
Marketing categoryBLA

Packages

50242-115-01 — 1 VIAL, SINGLE-USE in 1 CARTON (50242-115-01) / 2 mL in 1 VIAL, SINGLE-USE

Billed under HCPCS

J1307 — Injection, crovalimab-akkz, 10 mg Medicare Part B payment limit (ASP + 6%): $551.51

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.